iPath Series B Carbon Exchange-Traded Notes
8 hedge funds and large institutions have $2.7M invested in iPath Series B Carbon Exchange-Traded Notes in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 7 → 8 (+1)
40% less capital invested
Capital invested by funds: $4.5M → $2.7M (-$1.8M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$74.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$54.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$2.33M |
| 2 |
Jane Street
New York
|
-$82.1K |
GRN Hedge Fund Activity: Q4 2025 in Review
8 of the 8,252 institutional investors tracked by Wall St. Rank reported a position in iPath Series B Carbon Exchange-Traded Notes (GRN) for Q4 2025, worth a combined $2.7M — down 40% from $4.5M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new GRN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $74.6K. The largest seller was Flow Traders U.S., cutting an estimated $2.33M.
- 8 institutional investors held iPath Series B Carbon Exchange-Traded Notes (GRN) as of Q4 2025, up from 7 in Q3 2025.
- Funds reported $2.7M of iPath Series B Carbon Exchange-Traded Notes stock for Q4 2025, down 40% quarter-over-quarter.
- 1 fund opened new iPath Series B Carbon Exchange-Traded Notes positions in Q4 2025 and 0 closed out, a net change of +1 holder.
- The largest iPath Series B Carbon Exchange-Traded Notes buyer in Q4 2025 was JP Morgan Chase, an estimated $74.6K added.
- The largest iPath Series B Carbon Exchange-Traded Notes seller in Q4 2025 was Flow Traders U.S., an estimated $2.33M sold.
Based on aggregated 13F filings for Q4 2025.